发表论文

发表论文：
 

2024

  1. Zhichao Deng, Mingzhen Zhang*. Liposozyme for wound healing and inflammation resolution. Nature Nanotechnology. 2024. DOI: 10.1038/s41565-024-01656-8
  2. Xiangji Yan, Jian Song, Yujie Zhang, Mei Yang, Zhichao Deng, Bowen Gao, Yuanyuan Zhu, Chenxi Xu, Chenguang Ding*, Mingzhen Zhang*, and Baojun Zhang*. Platelet-inspired nanomedicine targeting activated neutrophils to alleviate ulcerative colitis by free radicals scavenging and controlled neutrophil swarming. Nano Today. 2024, 54: 102139. https://doi.org/10.1016/j.nantod.2023.102139
  3. Cui Liu, Jiao Hu, Wenwen Yang, Jinyu Shi, Yiming Chen, Xing Fan, Wenhui Gao, Liangliang Cheng, Qingying Luo*, and Mingzhen Zhang*. Carbon dots enhanced peroxidase-like activity of platinum nanozyme. Nanoscale. 2024. DOI: 10.1039/D3NR04964G
  4.  Li SJ, Meng CT, Hao Q, Dai LY, Shi JH, Xu J, Zhou X, Zhao ST, Yang JF, Kang HF, Hou YZ, Zhang MZ, Ma XB, Tan MQ, and Wu Hao*. A multistage-responsive antibody-delivery strategy to improve immunotherapy for NSCLC brain metastasis by ultrasensitive releasing and tumor-anchoring. Advanced Functional Materials. 2024, 2312595. https://doi.org/10.1002/adfm.202312595
  5. Li JT, Jiang Song, Deng ZC, Yang J, Wang XQ, Gao BW, Zhu YY, Xu CX, Fu JL, Zhang YJ, Yang M*, Zhang MZ*, and Li RQ*. Robust reactive oxygen species modulator hitchhiking yeast microcapsule for colitis alleviation by trilogically intestinal microenvironment renovation. Bioactive Materials. 2024, 36: 203-220. https://doi.org/10.1016/j.bioactmat.2024.02.033
  6. Wei W, Cao HL, Shen D, Sun XY, Jia ZZ, and Zhang MZ*. Antioxidant carbon dots nanozyme loaded in thermosensitive in situ hydrogel system for efficient dry eye disease treatment. International Journal of Nanomedicine. 2024, 19: 4045-4060. https://doi.org/10.2147/IJN.S456613
  7. Zhu YY, Yang M, Deng ZC, Long DP, Gao BW, Xu CX, Fu JL, Zhao YR, Zhang YJ, Zhang MX, Zhang MZ*, and Chen LN*. Oral Biomimetic Metal-Phenolic Nanozyme with Quadruple Safeguards for Intestinal Homeostasis to Ameliorate Ulcerative Colitis. Journal of Nanobiotechnology. 2024. DOI : 10.1186/s12951-024-02802-z
  8. Yang M*, Zhu YY, He YL, Jiang Y, Zhou Q, Zhang MZ, Zhang GJ*, and Ma WQ*. Oral bomb effect nanotherapeutics alleviate ulcerative colitis by coordinated anti-inflammatory and pro-resolving strategies. Biomaterials Sciences. 2024. 
  9. Yang JF, Li ZQ, Shang N, Xu J, Zhou H, Luo W, Xu P, Lei WX, Zhou YC, Sheng XR, Zhang MZ, Ma XB, Tan MQ, and Wu H. Edible responsive-deposition nutrient delivery system with prolonged inflammatory retention for ameliorating ulcerative colitis. 2024. 
  10. Zepeng Li, Jingyue Qin, Youyou Feng, Yingcong Guo, Zhenting Zhao, Shirui Sun, Jin Zheng, Mingzhen Zhang, Jing Zhang, Yilei Zhang, Jing Wei*, Chenguang Ding* and Wujun Xu*. Mesoporous zinc-polyphenol nanozyme for attenuating renal ischemia-reperfusion injury. Nanomedicine. 2024. https://doi.org/10.1080/17435889.2024.2382667
  11. Zhenzhen Jia, Mengdi Yu, Seyedalireza Ghazimirsaeid, Yong Qu*, and Mingzhen Zhang*. An oxidative cleavage-based cruciform DNA nanostructure for in vivo hypochlorous acid visualization to monitor intestinal inflammation. Analytical Chemistry. 2024, 96(23):9621-9628. DOI: 10.1021/acs.analchem.4c01272
  12. Dan Wang, Wenqi Ma, Yujie Zhang, Yuanyuan Zhang, Yufeng Wang, Lei Sun, Jue Jiang, Lianying Jiao, Mingzhen Zhang*, and Qi Zhou*. A versatile nanoplatform carrying cascade Pt nanozymes remodeling tumor microenvironment for amplified sonodynamic/chemo therapy of thyroid cancer. Biomaterials. 2024. https://doi.org/10.1016/j.biomaterials.2024.122778
  13. Mingxin Zhang, Yunlong Liang, Lingmin Zhang, Ning Wang, Ying Zhou, Manli Cui*, Yana Ma*, and Mingzhen Zhang*. Oral carbon dot nanozymes with red fluorescence and superoxide dismutase-like activity for colitis bioimaging and inflammation management. Chemical Engineering Journal. 2024, 493: 152842. https://doi.org/10.1016/j.cej.2024.152842
  14. Yuhan Fu, Yuanyuan Zhang, Yujie Zhang, Runqing Li, Mei Yang, Ting Bai, Xiaoliang Zheng, Dongsheng Huang, Mingzhen Zhang, Kangsheng Tu*, and Qiuran Xu*. Nanoreactors with cascade catalytic activity reprogram the tumor microenvironment for enhanced immunotherapy by synchronously regulating Treg & Macrophage cells. ACS applied materials & interfaces. 2024. https://doi.org/10.1021/acsami.4c09830
  15. Jingyue Qin, Zepeng Li, Youyou Feng, Yingcong Guo, Zhenting Zhao, Shirui Sun, Jin Zheng, Mingzhen Zhang, Jing Zhang, Yilei Zhang, Jing Wei, Chenguang Ding and Wujun Xue. Reactive Oxygen Species-Scavenging Mesoporous Poly(tannic acid) Nanospheres Alleviate Acute Kidney Injury by Inhibiting Ferroptosis. ACS Biomater Sci Eng. 2024. https://doi.org/10.1021/acsbiomaterials.4c00844
  16. Wenni Tian, Muwen Lv, Mingzhen Zhang, Yuan Li, Mingyue Song, Yong Cao, and Jie Xiao. Synergistic Intervention in Insomnia via Circadian Rhythm Modulation. 2024.
  17. Jinfan Yang, Zhengqing Li, Mingzhen Zhang, Xiaobin Ma, Hao Wu* and Mingqian Tan*. Guidelines for assessment of in vivo intestinal anti-inflammatory capacity of food-derived nutrients. 2024.
  18. Huanyu Li, Meng Pan, Yifan Li, Hao Liang, Manli Cui, Mingzhen Zhang*and Mingxin Zhang*. Nanomedicine: the new trend and future of precision medicine for inflammatory bowel disease. 2024.
  19. Yuanyuan Zhang, Zhichao Deng, Bowen Gao, Yuanyuan Zhu, Chenxi Xu, Yujie Zhang, Yufeng Wang, Lianying Jiao, Hao Wu, Mingxin Zhang, Lingmin Zhang and Mingzhen Zhang*. Metabolic Reprogramming Nanomedicine Potentiates Colon Cancer Sonodynamic Immunotherapy by Inhibiting the CD39/CD73/ADO Pathway. 2024.
  20. Zhichao Deng, Can Li, Yujie Zhang, Yuanyuan Zhu, Chenxi Xu, Bowen Gao, Kelong Fan*, Mingzhen Zhang*, and Yanyan Jiang*. Deciphering the catalytic and pharmacological mechanisms of Coptis chinensis herbzymes to renovate intestinal microenvironment for colitis alleviation. 2024.
  21. Weijun Xu, Aili Suo*, Abdalrheem Aldai, Yaping Wang, Jingjing Fan, Yuxiang Xia, Jiaxuan Xu, Zhexi Chen, Huichen Zhao, Mingzhen Zhang and Junmin Qian*. Hollow Calcium/Copper Bimetallic Amplifier for Cuproptosis/Paraptosis/Apoptosis Cancer Therapy via Cascade Reinforcement of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction. ACS nano. 2024.
  22. Wenjing Wang, Guangrong Lu, Zhichao Deng, Yuanyuan Zhu, Chenxi Xu, Mei Yang, Yujie Zhang, Lanqi Wang, Xiaoling Huang, Changlong Xu* and Mingzhen Zhang*. Biocompatible antioxidant carbon dots nanozymes alleviate ulcerative colitis by comprehensively orchestrating intestinal homeostasis. 2024.
  23. Huanyu Li, Ziwei Yang, Chuanyu Zhang, Ting Bai, Zhichao Deng, Bowen Gao, Manli Cui, Weixuan Jing, Mingxin Zhang*, Xueyong Wei* and Mingzhen Zhang*. Prebiotic microcapsule encapsulating pterostilbene alleviate ulcerative colitis by orchestrating the intestinal microenvironment and activating the AHR/IL-22 pathway. 2024.
  24. Bowen Gao, Yujie Zhang, Zhichao Deng, Junlong Fu, Yuanyuan Zhu, Chenxi Xu, Chaojun Wei, Mei Yang, Jie Xiao, Xiaoling Huang and Mingzhen Zhang*. Oral administration of Momordica charantia-derived extracellular vesicles alleviates ulcerative colitis through comprehensive renovation of the intestinal microenvironment. 2024.
  25. Wenfang He, Chenguang Ding, Binqi Wang, Zhichao Deng, Taian Jin, Yiwei Shang, Danna Zheng, Mingzhen Zhang, Runqing Li, Juan Jin and Qiang He. An enzyme-mimicking reactive oxygen species scavenger targeting oxidative stress-inflammation cycle ameliorates IR-AKI by inhibiting pyruvate dehydrogenase kinase 4. Theranostics. 2024.
  26. Yuanru Zhao, Yujie Zhang, Yan Zhang, Yuanyuan Zhang, Zhichao Deng, Ting Bai, Mingxin Zhang, Jian Song, Mingzhen Zhang*. Biomimetic nanoplatform-medicated protective autophagy blockage augmenting sonodynamic and Ca2+-overload combined therapy for colon cancer. 2024.
  27. Yali Feng, Xiaoli Zhang, Juan Li, Shan Fu, Weicheng Xu, Jinfeng Liu, Yuan Yang, Tianyan Chen, Yingren Zhao, Dongmin Li, Mingzhen Zhang*, and Yingli He*. Ultra-small Quercetin-Based Nanotherapeutics Ameliorate Acute Liver Failure by Combatting Inflammation/Cellular Senescence Cycle. 2024.
  28. Mei Yang, Zhichao Deng, Yuanyuan Zhu, Chenxi Xu, Chenguang Ding, Yujie Zhang, Mingxin Zhang*, and Mingzhen Zhang*. Advancements in Herbal Medicine-based Nanozymes for Biomedical Applications. 2024.
  29. Meihong Chai, Shihua Wang, Liping Zhang, Baosen Yue*, Xueyan Zhen*, Mingzhen Zhang*. Leveraging Plant-Derived Nanovesicles for Advanced Nucleic Acid-Based Gene Therapy. 2024.
  30. Farhad Esmailzadeh, Iman Zare, Reza Taheri-Ledari, Mohammad Mehdi Salehi, Azadeh Ghaee, Mostafa Ghafuri, Jianliang Shen*, Meng Yu*, Mingzhen Zhang*. Engineered Nanozymes for Precision Diagnosis and Treatment of Human Diseases. 2024.
  31. Zhichao Deng, Yujie Zhang, Yuanyuan Zhu, Chenxi Xu, Bowen Gao, Wenlong Wang, Runqing Li, Chenguang Ding, Bin He, Xingzhuo Zhu, Mei Yang, Ting Liang, and Mingzhen Zhang*. Honeysuckle-derived carbon dots with robust catalytic and pharmacological activities for mitigating lung inflammation by inhibition of Caspase-4/GSDMD-dependent pyroptosis. 2024.

 

2023

  1. Gao WH, He JY, Chen L, Meng XQ, Ma YN, Liu C*, Zhang MZ*, Fan KL*, Pang D-W* and Yan XY*. Deciphering the catalytic mechanism of superior superoxide dismutase activity of carbon dot nanozyme. Nature Communications. 2023, 14: 160. (IF: 17.7). https://doi.org/10.1038/s41467-023-35828-2.
  2. Ma YN, Zhao JJ, Cheng LL, Li C, Yan XJ, Deng ZC, Zhang YJ, Liang J, Liu C and Zhang MZ*. Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics. Carbon. 2023, 204: 526-537. (IF: 11.3). https://doi.org/10.1016/j.carbon.2023.01.006.
  3. Jia ZZ#, Wei W#, Tu KS, Fang BY*, Zhang MZ*, and Shi LL*. Point-of-care monitoring of dry eye disease using lysozyme in tear based on commercial pregnancy test strips. Sensors and Actuators B-Chemical. 2023, 378: 133179. (IF: 9.22). https://doi.org/10.1016/j.snb.2022.133179
  4. Cao YM, Cheng K, Yang M, Deng ZC, Ma YN, Yan XJ, Zhang YY, Jia ZZ, Wang J, Tu KS*, Liang J* and Zhang MZ*. Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease. Journal of Nanobiotechnology. 2023, 21: 21. (IF=9.43). https://doi.org/10.1186/s12951-023-01770-0
  5. Zhang YJ#, Gao WH#, Ma YN, Cheng LL, Zhang L, Liu QG, Chen JY, Zhao YR, Tu KS*, Zhang MZ* and Liu C*. Integrating Pt nanoparticles with carbon nanodots to achieve robust cascade superoxide dismutase-catalase nanozyme for antioxidant therapy. Nano Today. 2023, 49: 101768. (IF=19.0). https://doi.org/10.1016/j.nantod.2023.101768
  6. Yan XJ，Meng LZ, Zhang XZ, Deng ZC, Gao BW, Zhang YJ, Yang M, Ma Y, Zhang YY, Tu KS, Zhang MZ*, and Xu QR. Reactive Oxygen Species-Responsive Nanocarrier Ameliorates Murine Colitisby Intervening Colonic Innate and Adaptive Immune Responses. Molecular Therapy. 2023, 31(5):1383-1401. (IF=12.9). https://doi.org/10.1016/j.ymthe.2023.02.017
  7. Zhang YJ#, Zhao JJ#, Zhang LM, Zhao YR, Zhang YY, Cheng LL, Wang D, Liu Cui, Zhang MX*, Fan KL*, and Zhang MZ*. A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage. Nano Today. 2023, 49: 101798. (IF: 19.0) https://doi.org/10.1016/j.nantod.2023.101798
  8. Geng XD, Du XC, Wang WJ, Zhang CM, Liu XD, Qu YY, Zhao MW, Li WF, Zhang MZ, Tu KS*, and Li YQ*. Confined cascade metabolic reprogramming nanoreactor for targeted alcohol detoxification and alcoholic liver injury management. ACS Nano. 2023, 17(8): 7443–7455. https://pubs.acs.org/doi/10.1021/acsnano.2c12075
  9. Zhou Y, Yan XJ, Yang M, Ma YN, Zhang YY, Cui ML*, Zhang MZ* and Zhang MX*. Oral delivery of therapeutic andrographolide/carbon monoxide (CO) donor for synergistic treatment of ulcerative colitis by anti-inflammation and pro-resolution. ACS Applied Materials & Interfaces. 2023 15, 30, 36061–36075. https://doi.org/10.1021/acsami.3c09342
  10. Yu H, Zhao HY, Zhang YJ, Hou YM, Li YQ, Zhang YY, Li Cheng, Zhang JJ*, Zhang MZ*, and An Ruifang*. Biomimetic nanoreactors for combinational chemo/chemodynamic therapy of choriocarcinoma through synergistic apoptosis and ferroptosis strategy. Chemical Engineering Journal. 2023, 472: 144690. https://doi.org/10.1016/j.cej.2023.144690
  11. Zhao YR, Xu JW, Zhang YY, Wu F, Zhao W, Li RQ, Zhang MZ*, Zhang YJ*, and Guo Cheng*. Biomimetic redox-responsive prodrug micelles with diselenide linkage for platinum nanozymes augmented sonodynamic/chemo combined therapy of colon cancer. Chemical Engineering Journal. 2023, 472: 144911. https://doi.org/10.1016/j.cej.2023.144911
  12. Zhang YY#, Zhang YJ#, Li RQ, Zhao YR, Zhao W, Wu F, Li C*, Hou YZ*, and Zhang MZ*. Immune adjuvant functionalized biomimetic nanocarriers combine sonodynamic therapy for enhanced cancer immunotherapy. Chemical Engineering Journal. 2023, 476: 145685. https://doi.org/10.1016/j.cej.2023.145685
  13. Ding CG, Wang B, Zheng J, Zhang MZ, Li Y, Shen HH, Guo YC, Zheng BX, Tian PX, Ding XM, and Xue WJ. Neutrophil membrane-inspired nanorobots act as antioxidants ameliorate ischemia reperfusion-induced acute kidney injury. ACS Applied Materials & Interfaces. 2023, 15(34): 40292–40303. https://doi.org/10.1021/acsami.3c08573
  14. Jia ZZ, Zhang YJ, Zhang CY, Wei XY*, and Zhang MZ*. Biosensing intestinal alkaline phosphatase by pregnancy test strips based on target-triggered CRISPR-Cas12a activity to monitor intestinal inflammation. Analytical Chemistry. 2023, 95(37): 14111–14118. https://pubs.acs.org/doi/10.1021/acs.analchem.3c03099
  15. 蔡鹏，张明真，高博雯*。植物源细胞外囊泡在炎症性肠病治疗中的应用[J]. 现代生物技术研究, 2023; 1: (1): 6-11.
  16. Liang YL, Zhang MZ, Zhang YJ *, Zhang MX*. Ultrasound sonosensitizers for tumor sonodynamic therapy and imaging: a new direction with clinical translation. Molecules. 2023, 28(18): 6484. https://doi.org/10.3390/molecules28186484
  17. Jia ZZ#, Liu YN#, Deng ZC, Zhang MZ*, and Tuo Hang*. Carbon dots with light-responsive oxidase-like activity for colorimetric dopamine detection and catalytic mechanism. Frontiers in Chemistry. 2023, 11: 1288418. https://doi.org/10.3389/fchem.2023.1288418
  18. Deng ZC, Ma WQ, Gao BW, Zhu YY, Zhang YJ, Zhang MX, Li RQ, and Zhang MZ*. Metal polyphenol network/cerium oxide artificial enzymes therapeutic nanoplatform for MRI/CT imaging-aided intestinal inflammation management. Nano Today. 2023, 53: 102044. https://doi.org/10.1016/j.nantod.2023.102044
  19. He WF#, Jin J#, Zheng SQ, Zhang H, Gao BW, Zhang MZ*, and He Q*. Plant-derived vesicle-like nanoparticles: clinical application exploration and challenges. International Journal of Nanomedicine. 2023, 18: 5671-5683. https://doi.org/10.2147/IJN.S428647
  20. Ma YN, Deng ZC, Gao BW, Xu CX, Yan XJ, Yang M, Zhang YJ, Tu KS, Zhao JJ*, Xu QR*, and Zhang MZ*. Macrophage-biomimetic liposomes delivery of carbon dots nanozymes ameliorate ulcerative colitis by modulating inflammation pathways and remodeling the redox microenvironment. Chemical Engineering Journal. 2023, 477: 146796. https://doi.org/10.1016/j.cej.2023.146796
  21. Lu GR#, Jia ZZ#, Zhang MZ*, and Xu CL*. A Ratiometric Fluorescent Sensor Based on Chelation Enhanced Fluorescence of Carbon Dots for Zinc Ion Detection. Molecules. 2023.

2022

  1. Yang M, Yang CH, Zhang YJ, Yan XJ, Ma YN, Zhang YY, Cao YM, Xu QR*, Tu KS* and Zhang MZ*. Orally pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis. Biomaterials Science. 2022, 10(4):1053-1067. (IF=7.59)
  2. Ma YN, Gao WH, Zhang YJ, Yang M, Yang XJ, Zhang YY, Li GY, Liu C*, Xu CL* and Zhang MZ*. Biomimetic MOF nanoparticles delivery of C-dot nanozyme and CRISPR/Cas9 system for sitespecific treatment of ulcerative colitis. ACS Applied Materials & Interfaces. 2022, 14(5), 6358−6369. (IF=10.38) 
  3. Gong LY, Zhang YJ, Zhang YL, Tu KS, Jiao LY, Xu QR, Zhang MZ*and Han SX*. All-in-one biomimetic banoplatform based on hollow polydopamine nanoparticles for synergistically enhanced radiotherapy of colon cancer. Small. 2022, e2107656. (IF=15.15) 
  4. Yan XJ, Yang CH, Yang M, Ma YN, Zhang YY, Zhang YJ, Liu C, Xu QR*, Tu KS* and Zhang MZ*. All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis. Journal of Nanobiotechnology. 2022, 20(1): 99. (IF=10.435) 
  5. Liu C#, Yan XJ#, Zhang YJ#, Yang M, Ma YN, Zhang YY, Xu QR*, Tu KS* and Zhang MZ*. Turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for treatment of ulcerative colitis. Journal of Nanobiotechnology. 2022, 20(1):206. (IF=10.435) 
  6. Wei W, Zhang YJ, Li RQ, Cao YM, Yan XJ, Ma YN, Zhang YY, Yang M* and Zhang MZ*. Oral delivery of pterostilbene by L-Arginine-mediated “nano-bomb” carrier for the treatment of ulcerative colitis. International Journal of Nanomedicine. 2022, 17, 603-616. (IF=7.03) 
  7. Xu JW#*, Yan XJ#, Zhang Y, Tu KS, Shen W, Tian ZQ, Zhao W* and Zhang MZ. Tunable paclitaxel release carrier using diselenide-disulfide balance as regulator. Journal of Industrial and Engineering Chemistry. 2022, 109, 359-371. (IF: 6.76)
  8. Zhang MX, Lu N, Li Q, Cui ML*, and Zhang MZ*. Editorial: drugs delivery system based on nanoparticles for inflammation and cancer therapy. Front. Mol. Biosci. 2022, 9: 938348. (IF=6.11)
  9. Fang BY*, Jia ZZ, Liu C, Tu KS, Zhang MZ, Zhang L*. A versatile CRISPR Cas12a-based point-of-care biosensor enabling convenient glucometer readout for ultrasensitive detection of pathogen nucleic acids. Talanta. 2022, 249:123657. (IF: 6.56)
  10. Zhang YJ, Zhao YR, Zhang YY, Liu QG, Zhang MZ*, and Tu KS*. The crosstalk between sonodynamic therapy and autophagy in cancer. Frontiers in Pharmacology. 2022, 13: 961725. (IF: 5.988)
  11. Du CX#, Zhang MZ#, Zhou HT#, Wang WJ, Zhang CM, Qu YY, Li WF*, Liu XD, Zhao MW, Tu KS*, and Li YQ*. Decoy nanozymes enable multi-target blockade of pro-inflammatory cascades to reverse bacterial sepsis. Research. 2022, 9767643. (IF: 11.05)
  12. Liu C, Hu J, Wei XY, Gao WH, Cheng LL, Pan GT, Luo QY*, Yin GZ*, and Zhang MZ. Carbon Nanodots-stabilized platinum nanoparticles with high peroxidase-like activity for versatile applications. Chemical Communications. 2022. (IF: 6.06) (Under review).
  13. Liu C, Wei XX, Zhang MZ, Hildebrandt N, Luo QY* and Jin ZW*. Nucleic acid hybridization enhanced luminescence for rapid and sensitive RNA and DNA based diagnostics. Anal Chem. 2022. (IF: 8.0).
  14. Therapeutic Albumin Nanoparticles Hitchhike Activated Neutrophil Across Vascular Barrier for Subcutaneous and Orthotopic Colon Cancer Therapy (In submission)

2021

  1. Gong LY, Zhang YJ, Liu CC, Zhang MZ* and Han SX*. Application of Radiosensitizers in Cancer Radiotherapy. International Journal of Nanomedicine. 2021; 16: 1083-1102. (IF=6.4) ( Highly cited)
  2. 颜湘冀，张玉洁，张明真*。中性粒细胞在溃疡性结肠炎中的作用机制及靶向治疗策略[J]. 右江医学, 2021; 49(2): 87-91
  3. Jia ZZ, Tu KS, Xu QR, Gao WH, Liu C, Fang BY* and Zhang MZ*. A novel disease-associated nucleic acid sensing platform based on split DNA-scaffolded sliver nanocluster. Analytica Chimica Acta. 2021. (IF=6.558)
  4. Wang XY#, Zhang MZ#, Woloshun R, Yu Y, Lee J, Flores S, Merlin D and Collins J. Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in Hamp KO Mice. Nutrients. 2021, 13(5), 1686. (IF=5.717)
  5. Ma YN, Qu XL, Liu C, Xu QR* and Tu KS*. Metal-organic frameworks and their composites towards bio-medical applications. Front. Mol. Biosci. 2021, 8: 805228. (IF=5.25)

2020

  1. An J, Hu YG, Chang K, Li C, Hou XL, Wang GL, Zhang XS, Liu B, Zhao YD* and Zhang MZ*. ROS-Augmented and Tumor-Microenvironment Responsive Biodegradable Nanoplatform for Enhancing Chemo-Sonodynamic Therapy. Biomaterials. 2020; 234: 119761. (IF=10.3)
  2. Fang BY*, Guo P, Yang M, Ma YN, Yan XJ, Jia ZZ, Gao WH, Ahmad S, Xu CL, Liu C and Zhang MZ*. A Novel Fluorescent Enhancing Platform Based on DNA-scaffolded Silver Nanoclusters for Potential Inflammatory Bowel Disease-associated MicroRNA Detection. Talanta. 2020; 218: 121122. (IF=5.3)
  3. Yang CH, Zhang MZ, Lama S, Wang LX and Merlin D. Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis. Journal of Controlled Release. 2020; 323: 293-310. (IF=7.877)
  4. Yang CH, Zhang MZ, Sung J, Wang LX, Jung Y and Merlin D. Isolation and Characterization of Exosomes from Mouse Feces. Bio-protocol. 2020; 10(8): e3584.
  5. Shi Q, Cheng YH, Dong XM, Zhang M, Pei C and Zhang MZ*. Effects of rhaponticin on retinal oxidative stress and inflammation in diabetes through NRF2/HO-1/NF-kB signaling. Journal of Biochemical and Molecular Toxicology. 2020; e22568. (IF=3.606)
  6. Yang M, Zhang YJ, Ma YN, Yan XJ, Gong LY, Zhang MZ* and Zhang BJ*. Nanoparticle-based therapeutics of inflammatory bowel diseases: the current state and prospects. Journal of Bio-X Research (2020) 3:193–209.
  7. Liu C*, Zhang F, Hu J and Zhang MZ. A mini review on pH-sensitive photoluminescence in carbon nanodots. Frontiers in Chemistry. 

2019

  • Zhang MZ*, Yang CH, Yan XJ, Sung JK, Garg P and Merlin D. Highly Biocompatible Functionalized Layer-by-Layer Ginger Lipid Nano Vectors Targeting P-Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Advanced Therapeutics. 2019; 1900129. (Wiley new journal)
  • Yang M, Zhang F, Yang C, Wang L, Sung J, Garg P, Zhang MZ* and Merlin, D. Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer. Journal of Crohn's and Colitis. 2019. (IF=7.827)
  • Wang X, Zhang MZ, Flores SR, Woloshun RR, Yang C, Yin L, Xiang P, Xu X, Garrick MD, Vidyasagar S, Merlin D and Collins JF*. Oral Gavage of Ginger Nanoparticle-Derived Lipid Vectors Carrying Dmt1 siRNA Blunts Iron Loading in Murine Hereditary Hemochromatosis. Molecular Therapy. 2019; 27(3):493-506. (IF=8.402)
  • Li C, Yang XQ, Zhang MZ, Song YY, Cheng K, An J, Zhang XS, Xuan Y, Liu B, Zhao YD. In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene-and Photothermal Therapy. Theranostics. 2018; 8(20):5662. (IF=8.063)
  • Zhang MZ*, Xu CL, Wen LQ, Han MK, Xiao B, Zhou J and Merlin D. A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Research. 2016; 76(24), 7208-7218. (IF=8.378)
  • Zhang MZ*, Viennois E, Prasad M, Zhang YC, Wang LX, Zhang Z and Merlin D. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016; 101:321-340. (IF=10.273)
  • Zhang MZ, Yu Y, Yu RN, Wan M, Zhang RY and Zhao YD*. Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide. Small. 2013; 9:4183-4193. (IF=10.856)  
  • Zhang MZ*, Xiao B, Wang H, Han MK, Zhang Z, Viennois E and Merlin D. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Molecular Therapy. 2016; 24(10):1783-96. (IF=8.402)
  • Zhang MZ*, Xu CL, Liu DD, Han MK, Wang LX and Merlin D. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. Journal of Crohn’s and Colitis. 2018; 12(2): 217-229. (IF=7.827)
  • Zhang MZ*, Viennois E, Xu CL and Merlin D. Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers. 2016; e1134415.
  • Zhang MZ*, Collins JF and Merlin D. Do Ginger-derived nanoparticles present an attractive treatment strategy for inflammatory bowel disease? Nanomedicine. 2016; 3035-3037. (IF=4.717)
  • Zhang MZ*, Wang XY, Han MK, Collins JF and Merlin D. Oral administration of ginger-derived nano-lipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine. 2017; 12(16), 1927-1943. (IF=4.717)
  • Zhang MZ, Yu RN, Chen J, Ma ZY and Zhao YD*. Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells. Nanotechnology. 2012; 23:485104. (IF=3.399)
  • Zhang MZ, Li C, Fang BY, Yao MH, Ren QQ, Zhang L and Zhao YD*. High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting. Nanotechnology. 2014; 25:255102. (IF=3.399)
  • Zhang MZ* and Merlin D. Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis. Inflammatory Bowel Diseases. 2018; 24(7):1401-1415. (IF=4.005)